Cargando…
The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients
BACKGROUND: Gastric cancer (GC) is one of the most common malignancies, and the liver is the most common site of hematogenous metastasis of GC. AMIGO2 is a type I transmembrane protein that has been implicated in tumour cell adhesion in adenocarcinomas; however, its importance in GC remains undeterm...
Autores principales: | Goto, Keisuke, Morimoto, Masaki, Osaki, Mitsuhiko, Tanio, Akimitsu, Izutsu, Runa, Fujiwara, Yoshiyuki, Okada, Futoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925171/ https://www.ncbi.nlm.nih.gov/pubmed/35296279 http://dx.doi.org/10.1186/s12885-022-09339-0 |
Ejemplares similares
-
Establishment of an antibody specific for AMIGO2 improves immunohistochemical evaluation of liver metastases and clinical outcomes in patients with colorectal cancer
por: Goto, Keisuke, et al.
Publicado: (2022) -
AMIGO2 as a novel indicator of liver metastasis in patients with colorectal cancer
por: Tanio, Akimitsu, et al.
Publicado: (2021) -
Inflammation-Related Carcinogenesis: Lessons from Animal Models to Clinical Aspects
por: Okada, Futoshi, et al.
Publicado: (2021) -
AMIGO2 contained in cancer cell-derived extracellular vesicles enhances the adhesion of liver endothelial cells to cancer cells
por: Izutsu, Runa, et al.
Publicado: (2022) -
AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk
por: Iida, Yuki, et al.
Publicado: (2023)